Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 465

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 465
---
, LLC (“Point72 Associates”). Pursuant to an investment management agreement, Point72 Asset Management, L.P. (“Point72 Asset Management”) maintains investment                     
 and voting power with respect to the securities held by certain investment funds it manages, including Point72 Associates. Point72 Capital Advisors, Inc. (“Point72 Capital Advisors”) is the general partner of Point72 Asset Management, L.P.           
 Mr. Steven A. Cohen controls each of Point72 Asset Management, L.P. and Point72 Capital Advisors, Inc. Each of Point72 Asset Management, Point72 Capital Advisors, and Mr. Cohen may be deemed to beneficially own the securities held by Point72         
 Associates reflected herein. Each of Point72 Asset Management, Point72 Capital Advisors, and Mr. Cohen disclaims beneficial ownership of any such securities. The address for Point72 Associates is c/o Point72 Asset Management, 72 Cummings Point Road, 
 Stamford, CT 06902.                                                                                                                                                                                                                                       |

| (6) | Consists of (i) 22,869 shares of common stock held directly by Mr. Lennon; (ii) 236,809 shares issuable                                                                          
 upon the exercise of options within 60 days of January 30, 2025; and (iii) 16,250 shares issuable upon the vesting of restricted stock units within 60 days of January 30, 2025. |

- 316 -

| (7) | Consists of (i) 27,822 shares of common stock held directly by Mr. Giacobello; (ii) 448,270 shares                                                                                       
 issuable upon the exercise of options within 60 days of January 30, 2025; and (iii) 6,750 shares issuable upon the vesting of restricted stock units within 60 days of January 30, 2025. |

| (8) | Consists of (i) 100,000 shares of common stock held directly by Mr. Ball; (ii) 197,943 shares of common                                                                                        
 stock issuable upon the exercise of options within 60 days of January 30, 2025 and (iii); 5,000 shares issuable upon the vesting of restricted stock units within 60 days of January 30, 2025. |

| (9) | Consists of (i) 1,171,543 shares of common stock held indirectly by the Anishka Family Trust, (ii) 639,698